A multi-center retrospective study on the clinical prognosis of limb osteosarcoma
Jia HAN,Yi-yang YU,Su-jia WU,Zhen WANG,Wei-bin ZHANG,Ming ZHAO,Yang YAO,Yong-cheng HU,Wen-jian WANG,Xiao-zhou LIU,Wen-xi YU,Jie CHENG,Li-li YU,Qi-yuan BAO,Xiu-chun YU,Guo-chuan ZHANG
DOI: https://doi.org/10.3969/j.issn.2095-252X.2018.01.003
2018-01-01
Abstract:Objective To explore effects of clinical factors on the prognosis of limb osteosarcoma. Methods Clinical data of 479 patients with limb osteosarcoma, registered from June 2000 to March 2016 in seven cancer centers in China, were retrospectively collected. Clinical conditions, treatment method, complication, recurrence and metastasis as well as prognosis were recorded and analyzed. Kaplan-Meier survival curve and Cox regression model were used to analyze the correlation between the survival rate and variables factors. Results There were 292 males and 187 females among 479 patients, aged from 3 to 74 years ( average 21.4 years ). Tumors located around the knee joint in 396 patients ( 253 cases of the distal femur, 125 cases of the proximal tibia and 18 cases of the proximal fibula ), while beyond the knee in 83 patients ( 24 cases of the proximal femur, 17 cases of the distal tibia, 34 cases of the proximal humerus, 5 cases of the distal humerus and 3 cases of the radius ). 3 and 5-year overall survival were 71.0％, 60.0％, respectively. 3 and 5-year disease-free survival were 54.0％, 46.0％, respectively. 5-year overall survival were 73.0％ standard chemotherapy and 55.9％ non-standard chemotherapy; 48.7％ three medicine combination ( DDP +IFO + ADM ) and 66.0％ four medicine combination ( DDP + IFO + ADM + MTX ) preoperatively; 51.5％ three medicine combination ( DDP + IFO + ADM ) and 66.2％ four medicine combination ( DDP + IFO + ADM + MTX ) postoperatively; 93.3％ tumor necrosis rate ≥90.0％ and 40.3％ tumor necrosis rate < 90.0％; 61.9％ limb-salvage surgery and 43.3％ amputation; 61.9％ Enneking stage II and 25.1％ Enneking stage III; 93.5％ no recurrence, 46.3％local recurrence, 20.7％ lung metastasis and 10.1％ recurrence and metastasis postoperatively. Single factor analysis showed that standard chemotherapy, chemotherapy regimens, tumor necrosis rate, surgery, the Enneking stage and recurrence and metastasis were important to the prognosis of limb osteosarcoma. Cox regression analysis showed that standard chemotherapy, tumor necrosis rate, surgery approach and recurrence and metastasis were independent factors to the prognosis of limb osteosarcoma. Conclusions Survival rate of patients with limb osteosarcoma can be significantly improved by combining the standard chemotherapy and surgery. Recurrence and metastasis, non-standard chemotherapy severely affect the prognosis of limb osteosarcoma.